Sensex
84,544.31 profit arw 1,359.51 (1.63%)
Nifty
25,790.95 profit arw 375.15 (1.48%)
Nasdaq
18,013.98 profit arw 440.68 (2.51%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
IPO

IPO Details


Gland Pharma Ltd
Registered Office: Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal, Hyderabad - 500043, Telangana
Phone: 91-40-30510999
Email: investors@glandpharma.com
Website: www.glandpharma.com
Initial public offer of 43196968 equity shares of face value of Re. 1 each (equity shares) of Gland Pharma Limited (Company or Issuer) for cash at a price of Rs.1500 Per equity share (including a share premium of Rs.1499 per equity share) aggregating Rs.6479.55 crores (The Offer) comprising a fresh issue of 8,333,333 equity shares aggregating up to Rs. 1250 crores on (The fresh issue) and an offer for sale of 34,863,635 equity shares, including 19,368,686 equity shares by Fosun Pharma Industrial Pte. Ltd (promoter selling shareholder) and 10,047,435 equity shares by Gland Celsus Bio Chemicals Private Limited, 3,573,014 equity shares By Empower Discretionary Trust, and 1,874,500 equity shares by Nilay Discretionary Trust (collectively, the other selling shareholders and collectively With the promoter selling shareholder are referred to as the selling shareholders, and such equity shares, the offered shares) aggregating up to Rs. 5229.55 crores (the offer for sale). The offer shall constitute 26.46% of the post-offer paid-up equity share capital of the company. The face value of Equity shares is Re.1 each. The offer price is Rs.1500 per equity share and is 1500 times the face value of the Equity Shares. The Anchor Investor Offer Price is Rs.1500 per Equity Share.
Issue Money Payable On
Opens On Closes On Application Allotment
09-Nov-2020 11-Nov-2020 ₹ 1,500.00 ₹ 0.00
Minimum Application for shares in Nos : 10 Further Multiples of : 10
(₹)Cr. Lead Managers to the Issue
Project Cost 1,250.00 Citigroup Global Markets India Pvt Ltd
Project Financed through Current Offer 6,479.55
Post Issue Equity Share Capital 163.28
Issue Price ₹1,500.00
Projects
Funding incremental working capital requirements of the company
Funding capital expenditure requirements of the company
General corporate purposes
Promoted By
Fosun Pharma Indust. Pte. Ltd
Shanghai Fosun Pharma. Group
Listing At
BSE
NSE
Registrar to the Issue
Link Intime India Pvt Ltd

INDIAN INDICES

Sensex

84,544.31 1,359.51 (1.63%)

Nifty

25,790.95 375.15 (1.48%)

GLOBAL INDICES

USD

83.95 -0.07 (-0.08%)

NASDAQ

18,013.98 440.68 (2.51%)

HANG SENG

18258.57 245.41(1.36%)